MeiraGTx Holdings plc
MeiraGTx Holdings plc (MGTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MGTX · as of Jun 8, 2026
Key Statistics
Explore MeiraGTx Holdings plc Data
mgtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The MGTX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $25.00, representing +173.22% upside from the current price of $9.15.
Competitors & Peers
mgtx competitorsMGTX
ABSI
ARVN
ATXS
AVBP
DNAStock Performance
Full HistoryAbout MeiraGTx Holdings plc
MeiraGTx Holdings plc a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, includin…
what is meiragtx holdings plc · mgtx stock overview · meiragtx holdings plc company profile · who is meiragtx holdings plc ceo · mgtx NASDAQ · meiragtx holdings plc headquarters · meiragtx holdings plc business segments
About Stock Overview & Key Data
MeiraGTx Holdings plc (MGTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 8, 2018. As of the latest trading session, MGTX stock price is $9.15, with a market capitalization of $841.8M. The stock has returned +43.83% over the past 12 months and +14.34% year-to-date.
According to 6 Wall Street analysts, the consensus rating for MeiraGTx Holdings plc stock is Buy, with an average 12-month price target of $25.00. In fiscal year 2025, MeiraGTx Holdings plc reported revenue of $81.4M and net income of -$114.2M. For detailed data — including MeiraGTx Holdings plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MeiraGTx Holdings plc (MGTX) stock price is $9.15. The stock is traded on NASDAQ under the ticker symbol MGTX. The 52-week range is $5.24 – $11.85.